Munich Reinsurance Co Stock Corp in Munich acquired a new position in Procter & Gamble Company (The) (NYSE:PG - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 8,346 shares of the company's stock, valued at approximately $1,282,000.
Other institutional investors also recently bought and sold shares of the company. Ameriflex Group Inc. grew its stake in shares of Procter & Gamble by 89.2% during the 3rd quarter. Ameriflex Group Inc. now owns 21,631 shares of the company's stock valued at $3,324,000 after purchasing an additional 10,200 shares during the period. First Trust Advisors LP increased its position in shares of Procter & Gamble by 2.8% during the 3rd quarter. First Trust Advisors LP now owns 1,654,549 shares of the company's stock valued at $254,221,000 after purchasing an additional 44,849 shares during the last quarter. HUB Investment Partners LLC lifted its stake in shares of Procter & Gamble by 25.6% in the 3rd quarter. HUB Investment Partners LLC now owns 34,382 shares of the company's stock worth $5,283,000 after purchasing an additional 7,000 shares during the period. Legacy Capital Group California Inc. boosted its holdings in shares of Procter & Gamble by 11.3% in the third quarter. Legacy Capital Group California Inc. now owns 2,037 shares of the company's stock worth $313,000 after buying an additional 206 shares during the last quarter. Finally, Neo Ivy Capital Management bought a new stake in Procter & Gamble during the third quarter valued at approximately $600,000. Institutional investors own 65.77% of the company's stock.
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on PG shares. Barclays set a $155.00 price target on shares of Procter & Gamble in a research note on Friday, January 16th. Jefferies Financial Group upgraded Procter & Gamble from a "hold" rating to a "buy" rating and lifted their target price for the company from $156.00 to $179.00 in a research report on Tuesday, December 16th. Piper Sandler assumed coverage on Procter & Gamble in a report on Wednesday, January 7th. They set a "neutral" rating and a $150.00 price target for the company. JPMorgan Chase & Co. upgraded Procter & Gamble from a "neutral" rating to an "overweight" rating and upped their price target for the stock from $157.00 to $165.00 in a research report on Friday, January 23rd. Finally, Erste Group Bank raised Procter & Gamble from a "hold" rating to a "buy" rating in a research report on Wednesday, February 18th. Fourteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $168.33.
Get Our Latest Analysis on PG
Key Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Multiple dividend-themed pieces reaffirm PG’s status as a Dividend King/Aristocrat, underscoring steady dividend growth and defensive appeal for income-focused investors; that support can reduce downside for long-term holders. Dividend Aristocrats in a Shaky Market
- Neutral Sentiment: Market context is jittery (rising VIX, weak consumer sentiment and still-elevated Treasury yields); that macro uncertainty is affecting broad equity flows and may amplify short-term moves in consumer staples despite PG’s defensive profile. Dividend Aristocrats in a Shaky Market
- Negative Sentiment: A recent compendium of analyst notes flags margin pressure for Procter & Gamble, creating concern about near-term profitability and earnings leverage. That negative analyst tone can weigh on the stock. Top Research Reports for Procter & Gamble, American Express & TJX
- Negative Sentiment: Reports show PG shares have recently fallen more steeply than the broader market, indicating stronger selling pressure in short-term trading sessions. That price action can feed momentum-driven outflows. Procter & Gamble (PG) Falls More Steeply Than Broader Market
- Negative Sentiment: Insider selling was reported recently, which investors often view as a near-term negative signal and can amplify caution among holders and prospective buyers. Procter & Gamble NYSE: PG Shares Down 2.3% Following Insider Selling
Procter & Gamble Stock Down 0.1%
PG opened at $153.80 on Friday. The stock has a market cap of $357.43 billion, a price-to-earnings ratio of 22.79, a price-to-earnings-growth ratio of 5.13 and a beta of 0.37. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72. The firm's fifty day moving average is $152.35 and its 200 day moving average is $151.16. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $179.99.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Thursday, January 22nd. The company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.86 by $0.02. The business had revenue of $22.21 billion for the quarter, compared to the consensus estimate of $22.36 billion. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The business's revenue was up 1.5% on a year-over-year basis. During the same period in the previous year, the business earned $1.88 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd were issued a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend was Friday, January 23rd. Procter & Gamble's payout ratio is 62.52%.
Insider Activity
In other Procter & Gamble news, insider Moses Victor Javier Aguilar sold 15,169 shares of the business's stock in a transaction on Friday, February 13th. The shares were sold at an average price of $162.28, for a total value of $2,461,625.32. Following the sale, the insider owned 44,735 shares in the company, valued at $7,259,595.80. The trade was a 25.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Marc S. Pritchard sold 95,903 shares of the stock in a transaction dated Friday, January 23rd. The shares were sold at an average price of $151.15, for a total transaction of $14,495,738.45. Following the transaction, the insider directly owned 182,607 shares of the company's stock, valued at $27,601,048.05. This trade represents a 34.43% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 348,618 shares of company stock valued at $55,462,643 in the last quarter. Company insiders own 0.20% of the company's stock.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report